(S)-4-amino-1-(2-hydroxy-3-(trityloxy)propyl)pyrimidin-2(1H)-one, 96%, 1g

7-Bromo-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine, 98%, 250mg

1-Phenyl-3-(thiophen-2-yl)-1h-pyrazole-4-carboxylic acid, 97%, 1g

5-Bromo-7-isopropyl-1H-indazole, 95.0%, 1g

1-Isopropylcyclohexanol, 98%, 1g

Methyl-(2-morpholin-4-yl-1-phenyl-ethyl)-amine, 95.0%, 1g

ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate monohydrochloride, 50mg

3-(1-HYDROXYETHYL)PHENYL ETHYL(METHYL)CARBAMATE, 95.0%, 5g

1-(2-Nitrobenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline, 98%, 100mg

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 5 ml, 100000 dalton(s), 12 pièce(s)

5-Bromo-2-(bromomethyl)pyridine hydrobromide, 97.0%, 250mg

3,6,9,12,15-Pentaoxaheptadecane-1,17-diol, 95.0%, 100g